Skip to main content

Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

Volume 15, Number 20, August 2008

Articles

Laminin-332-Integrin Interaction: A Target For Cancer Therapy?
pp. 1968-1975(8)
Authors: Tsuruta, Daisuke; Kobayashi, Hiromi; Imanishi, Hisayoshi; Sugawara, Koji; Ishii, Masamitsu; Jones, Jonathan C.R.

Favourites:
ADD

Platelet-Monocyte Interactions - A Dangerous Liaison Linking Thrombosis, Inflammation and Atherosclerosis
pp. 1976-1980(5)
Authors: Seizer, Peter; Gawaz, Meinrad; May, Andreas E.

Favourites:
ADD

Substrates and Inhibitors of Human Multidrug Resistance Associated Proteins and the Implications in Drug Development
pp. 1981-2039(59)
Authors: Zhou, Shu-Feng; Wang, Lin-Lin; Di, Yuan M.; Xue, Charlie Changli; Duan, Wei; Li, Chun Guang; Li, Yong

Favourites:
ADD

Enhancing Drug Discovery Through In Silico Screening: Strategies to Increase True Positives Retrieval Rates
pp. 2040-2053(14)
Authors: Kirchmair, J.; Distinto, S.; Schuster, D.; Spitzer, G.; Langer, T.; Wolber, G.

Favourites:
ADD
Favourites:
ADD

Identification of Apoptotic Drugs: Multiparametric Evaluation in Cultured Hepatocytes
pp. 2071-2085(15)
Authors: Gomez-Lechon, Maria J.; O'Connor, Jose Enrique; Lahoz, Agustin; Castell, Jose V.; Donato, Maria Teresa

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more